Bringing onco‐innovation to Europe’s healthcare systems: The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine
Denis Horgan, Gennaro Ciliberto, Pierfranco Conte, Giuseppe Curigliano, Luis Seijo, Luis M. Montuenga, Marina Garassino, Frederique Penault‐llorca, Fabrizia Galli, Isabelle Ray‐coquard, Denis Querleu, Peter Riegman, Keith Kerr, Hein Van Poppel, Anders Bjartell, Giovanni Codacci‐pisanelli, Jasmina Koeva‐balabanova, Angelo Paradiso, Zorana Maravic, Vassiliki Fotaki
- European Alliance for Personalized Medicine
- National Cancer Institute Regina Elena
- University of Padova
- University of Milan
- University of Navarra
- Spanish Center for Biomedical Research Network in Oncology (CIBERONC)
- Istituto Nazionale dei Tumori
- University of Auvergne
- Associazione aBRCAdaBRA Onlus
- Claude Bernard University Lyon 1
- University of Aberdeen
- University Hospitals Leuven
- Skåne University Hospital
- Sapienza University of Rome
- Bulgarian Association for Personalised Medicine
- Istituto Tumori 'Giovanni Paolo II'
- Digestive Cancers Europe
- Spanish National Cancer Research Center (CNIO)
- European Institute of Oncology
- KUZ‐Coalition of Association in Healthcare
- Antwerp University Hospital
- The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
- University of Naples Federico II
- Centre Léon Bérard
- Erasmus University Medical Center
- No affiliation available (private)
- University College Dublin
- CEINGE Biotecnologie Avanzate s.c. a r.l.
- CIBER Enfermedades Respiratorias (CIBERES)
Research output: Contribution to journal › Article › peer-review